Dasatinib Clinical Trials
Here are the 6 most popular medical studies for dasatinib
Monoclonal Antibodies
Blinatumomab + Combination Chemotherapy or Dasatinib + Prednisone + Blinatumomab for Acute Lymphoblastic Leukemia in Older Patients
Recruiting1 awardPhase 2
Birmingham, Alabama
This trial is studying the side effects and efficacy of blinatumomab and combination chemotherapy or dasatinib and prednisone in treating older patients with acute lymphoblastic leukemia.
Tyrosine Kinase Inhibitor
Dasatinib + Quercetin for Adults at Risk for Alzheimer's Disease
Recruiting1 awardPhase 1 & 2
Boston, Massachusetts
This trial will study whether giving Dasatinib and Quercetin (D+Q) to older adults at risk of Alzheimer's disease may help improve cognition and prevent progression to Alzheimer's disease.
Popular filter options for dasatinib trials
Clinical Trials With No Placebo
View 55 medical studies that do not have a placebo group.
Bcl-2 Inhibitor
Venetoclax + Dasatinib + Prednisone + Rituximab for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Recruiting1 awardPhase 1
Portland, Oregon
This trial is testing the effects of a combination of drugs on patients with a specific type of leukemia. The drugs may work by stopping the growth of cancer cells or by interfering with the ability of cancer cells to grow and spread.
Tyrosine Kinase Inhibitor
ABL001 + Dasatinib + Prednisone + Blinatumomab for Leukemia
Recruiting1 awardPhase 1
Chicago, Illinois
This trial is testing ABL001 in combination with dasatinib and prednisone as a possible treatment for B-cell Acute Lymphoblastic Leukemia (BCR-ABL+ B-ALL) or Chronic Myeloid Leukemia (CML) in lymphoid blast crisis.
Corticosteroid
Combination Therapy for Acute Lymphoblastic Leukemia in Children and Adolescents
Recruiting2 awardsPhase 3
Boston, Massachusetts
This trial is studying a new way to treat acute lymphoblastic leukemia (ALL). The new way involves using a new, updated set of risk factors to decide how strong the treatment will be and testing a new way of dosing a chemotherapy drug.
View More Dasatinib Trials
See another 39 many medical studies focused on dasatinib.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.